Status:

COMPLETED

Assessment of Cloth Face Coverings as Source Control Under Laboratory and Simulated Field Conditions

Lead Sponsor:

Emory University

Collaborating Sponsors:

Centers for Disease Control and Prevention

Conditions:

Masks

Eligibility:

All Genders

6-65 years

Phase:

NA

Brief Summary

Cloth masks have been evaluated as a potential substitute for personal protective equipment (PPE) and found lacking. Prior to the COVID-19 outbreak, the use of cloth masks was limited and the focus of...

Detailed Description

This study will recruit children ages 6-11 and adults ages 18-65 living in the Atlanta/Metro-Atlanta area. Participants will be randomly assigned to wear one of four different masks. These masks are ...

Eligibility Criteria

Inclusion

  • Children between the ages of 6-11 years old
  • Adults aged 18-65
  • Adults who have never smoked or have smoked less than 100 cigarettes in their lifetime

Exclusion

  • Adults unable to consent
  • Pregnant women
  • Prisoners
  • Cognitively impaired or Individuals with Impaired Decision-Making Capacity
  • Individuals who are not able to clearly understand English
  • Our research team does not have the resources required to translate our study materials or provide a translator for the study visit
  • Any known cardiorespiratory condition (including but not limited to asthma, bronchitis, cystic fibrosis, congenital heart disease, and emphysema)
  • Any known medical conditions that can be exacerbated by physical exercise (including but not limited to exercise-induced asthma, lower respiratory infections in the past 2 weeks, diabetes, hypertension, or epilepsy/seizure disorders)
  • Any physical disability from a medical, orthopedic, or neuromuscular disorder that would interfere with the performance of physical activities
  • Adult participants who are current or former smokers (i.e., an adult who has smoked 100 cigarettes in their lifetime and who currently smoke cigarettes, or an adult who has smoked 100 or more cigarettes in their lifetime)
  • Inability to move the head from side to side or bend at the waist
  • Inability to walk on a treadmill unassisted for the study duration
  • Inability to tolerate wearing a mask while completing physical activities
  • Anyone with symptoms of COVID-19 in the two weeks before their study visit
  • Presence of an acute upper respiratory tract infection or symptomatic rhinitis (i.e., blocked nasal passages, runny nose, or significant sneezing) on the day of the study

Key Trial Info

Start Date :

November 8 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 22 2022

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT05216939

Start Date

November 8 2021

End Date

February 22 2022

Last Update

May 17 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Emory Children's Center

Atlanta, Georgia, United States, 30322

2

Emory University

Atlanta, Georgia, United States, 30322